Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
12 min read
Anaplastic Large-Cell Lymphoma Indication Strategy Report 2026: Evidence, Targets, Competition and Market Outlook
27 August 2026
Evaluate Anaplastic Large-Cell Lymphoma in 2026: epidemiology, target biology, clinical competition, unmet need, deal activity and market attractiveness via Patsnap.
Latest Hotspot
12 min read
Verrucous Carcinoma Indication Strategy Report 2026: Evidence, Targets, Competition and Market Outlook
27 August 2026
Evaluate Verrucous Carcinoma with 2026 evidence on epidemiology, target biology, clinical competition, unmet need, deals and market attractiveness via Patsnap MCP..
Latest Hotspot
12 min read
Multicystic Dysplastic Kidney Indication Strategy Report 2026: Evidence, Targets, Competition and Market Outlook
27 August 2026
Evaluate Multicystic Dysplastic Kidney in 2026: epidemiology, target biology, clinical competition, unmet need, deal activity and market attractiveness via Patsnap.
Latest Hotspot
12 min read
Mucinous Adenocarcinoma Indication Strategy Report 2026: Evidence, Targets, Competition and Market Outlook
27 August 2026
Evaluate Mucinous Adenocarcinoma in 2026: epidemiology, target biology, clinical competition, unmet need, deal activity and market attractiveness via Patsnap MCP..
Latest Hotspot
12 min read
Dystrophy, Macular Indication Strategy Report 2026: Evidence, Targets, Competition and Market Outlook
27 August 2026
Evaluate Dystrophy, Macular with 2026 evidence on epidemiology, target biology, clinical competition, unmet need, deals and market attractiveness via Patsnap MCP..
Latest Hotspot
12 min read
Sarcomatoid Transitional Cell Carcinoma of the Renal Pelvis Indication Strategy Report 2026: Evidence, Targets, Competition and Market Outlook
27 August 2026
Evaluate Sarcomatoid Transitional Cell in 2026: epidemiology, target biology, clinical competition, unmet need, deal activity and market attractiveness via Patsnap.
Latest Hotspot
12 min read
Deoxyguanosine Kinase Deficiency Indication Strategy Report 2026: Evidence, Targets, Competition and Market Outlook
27 August 2026
Evaluate Deoxyguanosine Kinase in 2026: epidemiology, target biology, clinical competition, unmet need, deal activity and market attractiveness via Patsnap MCP..
Latest Hotspot
12 min read
squamous cell carcinoma of the anus Indication Strategy Report 2026: Evidence, Targets, Competition and Market Outlook
27 August 2026
Evaluate squamous cell carcinoma of the in 2026: epidemiology, target biology, clinical competition, unmet need, deal activity and market attractiveness via Patsnap.
Latest Hotspot
12 min read
Ichthyosis Prematurity Syndrome Indication Strategy Report 2026: Evidence, Targets, Competition and Market Outlook
27 August 2026
Evaluate Ichthyosis Prematurity in 2026: epidemiology, target biology, clinical competition, unmet need, deal activity and market attractiveness via Patsnap MCP..
Latest Hotspot
12 min read
Cystinosis, Late-Onset Juvenile or Adolescent Nephropathic Type Indication Strategy Report 2026: Evidence, Targets, Competition and Market Outlook
27 August 2026
Evaluate Cystinosis, Late-Onset in 2026: epidemiology, target biology, clinical competition, unmet need, deal activity and market attractiveness via Patsnap MCP..
Latest Hotspot
12 min read
Visceral Myopathy Familial External Ophthalmoplegia Indication Strategy Report 2026: Evidence, Targets, Competition and Market Outlook
27 August 2026
Evaluate Visceral Myopathy Familial in 2026: epidemiology, target biology, clinical competition, unmet need, deal activity and market attractiveness via Patsnap.
Latest Hotspot
12 min read
Cardiac Conduction System Disease Indication Strategy Report 2026: Evidence, Targets, Competition and Market Outlook
27 August 2026
Evaluate Cardiac Conduction System in 2026: epidemiology, target biology, clinical competition, unmet need, deal activity and market attractiveness via Patsnap MCP..